EVALUATION OF GROUNDWATER QUALITY OF SIWA OASIS

In discussing the water quality evaluation for use in different purposes, the author will briefly examine some of the major important water quality standards. These standards serve as a basis for appraisal of the results of chemical water analysis in terms of suitability of the water for various intended uses. According to total dissolved salts (TDS),  major  ions as cations ( Ca2+, Mg2+, Na+, K+), anions (CO₃2â», HCO₃â»Â  ,SOâ‚„2â», Clâ»), with some heavy metals such as Al3+, B3+ , Cd2+, Co2+, Cr3+, Cu2+, Fe3+, Mn2+,  Mo2+, Ni2+,  Pb2+, Sr2+, V2+   and Zn2+  The results  indicate  that  the samples of Nubian sandstone aquifer is suitable for drinking of human and livestock , suitable for laundry purposes and for irrigation. While the samples of Fractured dolomite limestone aquifer are unsuitable for drinking and irrigation.Â

Impacts of dietary inclusion of dried brewers’ grains on growth, carcass traits, meat quality, nutrient digestibility and blood biochemical indices of broilers

The current investigation aimed to evaluate the effect of dietary inclusion of dried brewers’ grains (DBG) on growth performance, carcass traits, meat quality, nutrient digestibility, blood biochemical constituents and antioxidant indices of broiler chickens. A total of 300 unsexed one-week-old Hubbard chicks were randomly allotted to five treatment groups. The dietary treatments consisted of a basal diet as the control and DBG groups (3%, 6%, 9% and 12%, respectively). The best feed conversion ratio (FCR) was found in the group of birds fed a diet containing 9% DBG, compared the other groups. Dressing and abdominal fat percentages decreased significantly but gradually with the elevated DBG level in the diets from 6% to 12%. The inclusion of DBG in broiler diets resulted in significant positive effects on all of the sensory evaluation indicators except appearance and tenderness. Broilers fed a diet containing 3% DBG had significant higher of digestion coefficients for crude protein than those fed on the other experimental diets. Based on growth performance and health status, 3% or 9% DBG may be the optimum percentages for inclusion in the diets of poultry until six weeks old. In addition, DBG exerted several health benefits in meat, which would be reflected positively on human health.Keywords: unconventional feedstuff, inclusion, performance, chicken, meat qualit

The Scientific Foundations of Forecasting Magnetospheric Space Weather

The magnetosphere is the lens through which solar space weather phenomena are focused and directed towards the Earth. In particular, the non-linear interaction of the solar wind with the Earth's magnetic field leads to the formation of highly inhomogenous electrical currents in the ionosphere which can ultimately result in damage to and problems with the operation of power distribution networks. Since electric power is the fundamental cornerstone of modern life, the interruption of power is the primary pathway by which space weather has impact on human activity and technology. Consequently, in the context of space weather, it is the ability to predict geomagnetic activity that is of key importance. This is usually stated in terms of geomagnetic storms, but we argue that in fact it is the substorm phenomenon which contains the crucial physics, and therefore prediction of substorm occurrence, severity and duration, either within the context of a longer-lasting geomagnetic storm, but potentially also as an isolated event, is of critical importance. Here we review the physics of the magnetosphere in the frame of space weather forecasting, focusing on recent results, current understanding, and an assessment of probable future developments.Peer reviewe

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Background: In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. Those trial participants with hypoxia (oxygen saturation <92% on air or requiring oxygen therapy) and evidence of systemic inflammation (C-reactive protein ≥75 mg/L) were eligible for random assignment in a 1:1 ratio to usual standard of care alone versus usual standard of care plus tocilizumab at a dose of 400 mg–800 mg (depending on weight) given intravenously. A second dose could be given 12–24 h later if the patient's condition had not improved. The primary outcome was 28-day mortality, assessed in the intention-to-treat population. The trial is registered with ISRCTN (50189673) and ClinicalTrials.gov (NCT04381936). Findings: Between April 23, 2020, and Jan 24, 2021, 4116 adults of 21 550 patients enrolled into the RECOVERY trial were included in the assessment of tocilizumab, including 3385 (82%) patients receiving systemic corticosteroids. Overall, 621 (31%) of the 2022 patients allocated tocilizumab and 729 (35%) of the 2094 patients allocated to usual care died within 28 days (rate ratio 0·85; 95% CI 0·76–0·94; p=0·0028). Consistent results were seen in all prespecified subgroups of patients, including those receiving systemic corticosteroids. Patients allocated to tocilizumab were more likely to be discharged from hospital within 28 days (57% vs 50%; rate ratio 1·22; 1·12–1·33; p<0·0001). Among those not receiving invasive mechanical ventilation at baseline, patients allocated tocilizumab were less likely to reach the composite endpoint of invasive mechanical ventilation or death (35% vs 42%; risk ratio 0·84; 95% CI 0·77–0·92; p<0·0001). Interpretation: In hospitalised COVID-19 patients with hypoxia and systemic inflammation, tocilizumab improved survival and other clinical outcomes. These benefits were seen regardless of the amount of respiratory support and were additional to the benefits of systemic corticosteroids. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Background: Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]) is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. The trial is underway at 177 NHS hospitals from across the UK. Eligible and consenting patients were randomly assigned (1:1) to receive either usual care alone (usual care group) or usual care plus high-titre convalescent plasma (convalescent plasma group). The primary outcome was 28-day mortality, analysed on an intention-to-treat basis. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936. Findings: Between May 28, 2020, and Jan 15, 2021, 11558 (71%) of 16287 patients enrolled in RECOVERY were eligible to receive convalescent plasma and were assigned to either the convalescent plasma group or the usual care group. There was no significant difference in 28-day mortality between the two groups: 1399 (24%) of 5795 patients in the convalescent plasma group and 1408 (24%) of 5763 patients in the usual care group died within 28 days (rate ratio 1·00, 95% CI 0·93–1·07; p=0·95). The 28-day mortality rate ratio was similar in all prespecified subgroups of patients, including in those patients without detectable SARS-CoV-2 antibodies at randomisation. Allocation to convalescent plasma had no significant effect on the proportion of patients discharged from hospital within 28 days (3832 [66%] patients in the convalescent plasma group vs 3822 [66%] patients in the usual care group; rate ratio 0·99, 95% CI 0·94–1·03; p=0·57). Among those not on invasive mechanical ventilation at randomisation, there was no significant difference in the proportion of patients meeting the composite endpoint of progression to invasive mechanical ventilation or death (1568 [29%] of 5493 patients in the convalescent plasma group vs 1568 [29%] of 5448 patients in the usual care group; rate ratio 0·99, 95% CI 0·93–1·05; p=0·79). Interpretation: In patients hospitalised with COVID-19, high-titre convalescent plasma did not improve survival or other prespecified clinical outcomes. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

Productive performance, fertility and hatchability, blood indices and gut microbial load in laying quails as affected by two types of probiotic bacteria

This study investigated two kinds of probiotic bacteria (Bacillus toyonensis, B1 and Bifidobacterium bifidum, B2) on laying Japanese quail’s performance, egg quality, fertility and hatchability, blood biochemical characteristics and microbiological parameters. A total of 270 mature quails (180 females and 90 males) were distributed into ten groups in a completely randomized design at eight weeks of age. The experimental groups were as follows: T1: basal diet only (control); T2-T5, basal diet plus 0.05, 0.075, 0.10 and 0.125% B1, respectively; T6: basal diet plus 0.10% B2; T7-T10: basal diet plus 0.05, 0.075, 0.10 and 0.125% B1 plus 0.05% B2, respectively. Results revealed that egg number (EN) and egg weight (EW) were gradually increased (P < 0.01) as the levels of both probiotic types increased. The feed conversion ratio (FCR) was significantly (P < 0.05) better within the total experimental period (8–20 weeks) due to B1 alone or/with B2 supplementation. Values of yolk percentage (Y%) were statistically (P < 0.01) higher only at 8–20 weeks of age and T10 recorded the highest value. By increasing the level of probiotics, fertility and hatchability percentages (F% and H%) were gradually increased (P < 0.01 and P < 0.05). Creatinine (CR) level was statistically reduced in birds fed T4 diet. Also, urea-N and aspartate aminotransferase (AST) levels were reduced in treated birds. The opposite was found regarding alkaline phosphatase (ALP). Conclusively, using B1 and B2 enhanced the productive performance, some egg quality traits, fertility and hatchability, digestive enzyme activities, and reduced the harmful bacteria in the gut of laying Japanese quail. Our findings could recommend to apply T4 (basal diet + 0.10 % B1), T6 (basal diet + 0.10% B2) and T9 (basal diet + 0.10% B1 + 0.05% B2) levels for the best results

Helminth parasites of fishes from two inland lakes in Egypt

Results of helminthological examination of 1243 fishes, caught from two inland lakes, with unique and contrasting hydrobiological features at Fayoum Governate in Egypt, are presented. General incidence of trematodes, cestodes, nematodes and acanthocephalans in fishes from the two lakes are compared. Eleven genera of digentic trematodes are reported for the first time in certain fishes of the two lakes. The incidence of single, simultaneous double or multiple infections with digentic trematodes in fishes of the two lakes are compared. The respective relationships of digentic trematode fauna of fishes from the two lakes with those from the River Nile and the Mediterranean Sea are suggested

Role of Quantiferon TB gold assays in monitoring the efficacy of antituberculosis therapy

Rationale: The impact of antituberculous treatment on (IFN)-γ response to mycobacterial tuberculosis antigens have been widely investigated but the results have been controversial. Aim of work: To evaluate the role of Quantiferon TB gold assays as one of the interferon-gamma release assays (IGRAs) for monitoring the efficacy of antituberculosis therapy in patients with active disease. Subjects and methods: Thirty patients with active pulmonary TB were enrolled in this cross-sectional study where they were subjected to history taking, clinical examination, chest X-ray, direct smear examination of sputum samples for AFB using Ziehl–Neelson stain performed on three visits; up on enrollment, 2 and 6 months later. Lowenstein Jensen medium cultures of sputum samples were done for isolation of Mycobacterium tuberculosis on first visit. All patients in the study group were subjected to QuantiFERON-TB Gold estimation on the three visits. Results: The mean sensitivity and specificity of QFT-G test was 85.9% and 62.6% respectively. Using χ2 analysis, there was a statistically significant association between QFT-G results and culture results upon enrollment and Acid fast bacilli positivity on second and third visits. Studying the changes in QFT-G results throughout the whole study period revealed a statistically significant decrease in number of QFT-G positive cases from 24/29 patients (82.8%) at first visit to 4/25 patients (16%) at the third visit. All 21/25 patients (84%) who became QFT-G negative at the end of the study had a complete clinical and microbiological recovery of the TB disease. Conclusion: The analysis of QFT-G assay results showed that in the majority of our TB patients there was a correlation between clinical treatment outcome and changes of IFN-γ response to M. tuberculosis-specific antigens